Publication Cover
Redox Report
Communications in Free Radical Research
Volume 21, 2016 - Issue 5
528
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Redox imbalance in peripheral blood of type 1 myotonic dystrophy patients

, , , , , & show all

References

  • Emery AE. Population frequencies of inherited neuromuscular diseases—a world survey. Neuromusc Disord 1991;1:19–29. doi: 10.1016/0960-8966(91)90039-U
  • Klein AF, Gasnier E, Furling D. Gain of RNA function in pathological cases: focus on myotonic dystrophy. Biochimie 2011;93:2006–12. doi: 10.1016/j.biochi.2011.06.028
  • Lee JE, Cooper TA. Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans 2009;37:1281–86. doi: 10.1042/BST0371281
  • Harper PS. Myotonic dystrophy. 3rd ed. London, UK: Saunders WB; 2001.
  • Toscano A, Messina S, Campo GM, Di Leo R, Musumeci O, Rodolico C, et al. Oxidative stress in myotonic dystrophy type 1. Free Radic Res 2005;39(7):771–76. doi: 10.1080/10715760500138932
  • Ihara Y, Mori A, Hayabara T, Namba R, Nobukuni K, Sato K, et al. Free radicals, lipid peroxides and antioxidants in blood of patients with myotonic dystrophy. J Neurol 1995;242(3):119–22. doi: 10.1007/BF00936882
  • Siciliano G, Pasquali L, Rocchi A, Falorni M, Galluzzi F, Rocco A, et al. Advanced oxidation protein products in serum of patients with myotonic disease type I: association with serum gamma-glutamyltransferase and disease severity. Clin Chem Lab Med 2005;43(7):745–47. doi: 10.1515/CCLM.2005.127
  • Rodriguez MC, Tarnopolsky MA. Patients with dystrophinopathy show evidence of increased oxidative stress. Free Radic Biol Med 2003;34(9):1217–20. doi: 10.1016/S0891-5849(03)00141-2
  • Vasilaki A, Mcardle F, Iwanejko LM, Mc Ardle A. Adaptive responses of mouse skeletal muscle to contractile activity: the effect of age. Mech Ageing Dev 2006;127(11):830–39. doi: 10.1016/j.mad.2006.08.004
  • Jackson MJ. Control of reactive oxygen species production in contracting skeletal muscle. Antioxid Redox Signal 2011;15(9):2477–86. doi: 10.1089/ars.2011.3976
  • Tidball JG, Wehling-Henricks M. The role of free radicals in the pathophysiology of muscular dystrophy. J Appl Physiol 2007;102(4):1677–86. doi: 10.1152/japplphysiol.01145.2006
  • Nikolić-Kokić A, Stević Z, Blagojević D, Davidović B, Jones DR, Spasić MB. Alterations in anti-oxidative defense enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients. Clin Chem Lab Med 2006;44:589–93. doi: 10.1515/CCLM.2006.111
  • Mathieu J, Boivin H, Meunier D, Gaudreault M, Bégin P. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 2001;56(3):336–40. doi: 10.1212/WNL.56.3.336
  • Tentori L, Salvati AM. Hemoglobinometry in human blood. Methods Enzymol 1981;76:707–15. doi: 10.1016/0076-6879(81)76152-4
  • Tsuchihashi M. Zur Kenntnis der Blutkatalase. Biochemistry 1923;Z140:65–74.
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–85. doi: 10.1038/227680a0
  • Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971;44:276–87. doi: 10.1016/0003-2697(71)90370-8
  • Manley BFJ. Multivariate statistical methods. A primer. London: Chapman and Hall; 1986.
  • Blagojević D, Buzadžić B, Korać B, Saičić ZS, Radojičić R, Spasić MB, Petrović VM. Seasonal changes in the antioxidant defense in ground squirrel (Citellus citellus): possible role of GSH-Px. JEPTO 1998;17:241–50.
  • Miljević Č, Nikolić-Kokić A, Saičić ZS, Milosavljević M, Blagojević D, Tosevski DL, et al. Correlation analysis confirms differences in antioxidant defence in the blood of types I and II schizophrenic male patients treated with anti-psychotic medication. Psych Res 2010;178(1):68–72. doi: 10.1016/j.psychres.2008.10.038
  • Bray RC, Cockle SA, Fielden EM, Roberts PB, Rotilio G, Calabrese L. Reduction and inactivation of superoxide dismutase by hydrogen peroxide. Biochem J 1974;139(1):43–8. doi: 10.1042/bj1390043
  • Usuki F, Takahashi N, Sasagawa N, Ishiura S. Differential signaling pathways following oxidative stress in mutant myotonin protein kinase cDNA-transfected C2C12 cell lines. Biochem Biophys Res Commun 2000;267(3):739–43. doi: 10.1006/bbrc.1999.2026
  • Comim CM, Mathia GB, Hoepers A, Tuon L, Kapczinski F, Dal-Pizzol F, et al. Neurotrophins, cytokines, oxidative parameters and funcionality in Progressive Muscular Dystrophies. An Acad Bras Cienc 2015; 87(3):1809–18.
  • Renard D. Serum CK as a guide to the diagnosis of muscle disease. Pract Neuro 2015; 15(2):121. doi:10.1136/practneurol-2014-001031.
  • Peterson CM, Johannsen DL, Ravussin E. Skeletal muscle mitochondria and aging: a review. J Aging Res 2012;2012:194821. doi: 10.1155/2012/194821
  • McArdle F, Spiers S, Aldemir H, Vasilaki A, Beaver A, Iwanejko L, et al. Preconditioning of skeletal muscle against contraction-induced damage: the role of adaptations to oxidants in mice. J Physiol 2004;561:233–44. doi: 10.1113/jphysiol.2004.069914
  • Jackson MJ. Free radicals generated by contracting muscle: by-products of metabolism or key regulators of muscle function? Free Radic Biol Med 2008;44(2):132–41. doi: 10.1016/j.freeradbiomed.2007.06.003
  • Reid MB, Khawli FA, Moody MR. Reactive oxygen in skeletal muscle. III. Contractility of unfatigued muscle. J Appl Physiol 1993;75:1081–87.
  • Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006;71:310–21. doi: 10.1016/j.cardiores.2006.02.019
  • Kimura T, Nakamori M, Lueck JD, Pouliquin P, Aoike F, Fujimura H, et al. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum Mol Genet 2005;14(15):2189–200. doi: 10.1093/hmg/ddi223
  • Muller FL, Song W, Liu Y, Chaudhuri A, Pieke-Dahl S, Strong R, et al. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic Biol Med 2006;40:1993–2004. doi: 10.1016/j.freeradbiomed.2006.01.036
  • Magaña JJ, Cisneros B. Perspectives on gene therapy in myotonic dystrophy type 1. J Neurosci Res 2011;89(3):275–85. doi: 10.1002/jnr.22551
  • Kumar A, Kumar V, Singh SK, Muthuswamy S, Agarwal S. Imbalanced oxidant and antioxidant ratio in myotonic dystrophy type 1. Free Radic Res 2014;48(4):503–10. doi: 10.3109/10715762.2014.887847

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.